225 related articles for article (PubMed ID: 6696534)
1. Hemodynamic effects of vasopressin, alone and in combination with nitroprusside, in patients with liver cirrhosis and portal hypertension.
Mols P; Hallemans R; Van Kuyk M; Melot C; Lejeune P; Ham H; Vertongen F; Naeije R
Ann Surg; 1984 Feb; 199(2):176-81. PubMed ID: 6696534
[TBL] [Abstract][Full Text] [Related]
2. Vasopressin and vasopressin plus nitroglycerin for portal hypertension. Effects on systemic and splanchnic hemodynamics and coronary blood flow.
Rector WG; Hossack KF
J Hepatol; 1989 May; 8(3):308-15. PubMed ID: 2499616
[TBL] [Abstract][Full Text] [Related]
3. Nitroprusside prevents adverse hemodynamic effects of vasopressin.
Gelman S; Ernst EA
Arch Surg; 1978 Dec; 113(12):1465-71. PubMed ID: 736781
[TBL] [Abstract][Full Text] [Related]
4. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
Bosch J; Kravetz D; Rodes J
Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
[TBL] [Abstract][Full Text] [Related]
5. Systemic and regional hemodynamic effects of isosorbide dinitrate in patients with liver cirrhosis and portal hypertension.
Mols P; Hallemans R; Melot C; Lejeune P; Naeije R
J Hepatol; 1989 May; 8(3):316-24. PubMed ID: 2732445
[TBL] [Abstract][Full Text] [Related]
6. Effects of vasopressin and nicardipine on hemodynamics and liver function in patients with cirrhosis: comparison with vasopressin alone.
Iwao T; Toyonaga A; Ikegami M; Oho K; Sumino M; Sakaki M; Shigemori H; Nakayama M; Sasaki E; Tanikawa K
J Hepatol; 1993 Nov; 19(3):345-52. PubMed ID: 8151095
[TBL] [Abstract][Full Text] [Related]
7. Portohepatic pressures, hepatic function, and blood gases in the combination of nitroglycerin and vasopressin: search for additive effects in cirrhotic portal hypertension.
Iwao T; Toyonaga A; Ikegami M; Sumino M; Oho K; Sakaki M; Nishizono M; Tanikawa K
Am J Gastroenterol; 1992 Jun; 87(6):719-24. PubMed ID: 1590307
[TBL] [Abstract][Full Text] [Related]
8. The effects of the combination of phentolamine and vasopressin on hepatic and systemic hemodynamics in cirrhotic portal hypertensive dog model.
Dan ZL; Zhao Q; Li SB
J Tongji Med Univ; 1991; 11(1):35-8. PubMed ID: 1875450
[TBL] [Abstract][Full Text] [Related]
9. Vasopressin-induced changes in splanchnic blood flow and hepatic and portal venous pressures in liver resection.
Bown LS; Ricksten SE; Houltz E; Einarsson H; Söndergaard S; Rizell M; Lundin S
Acta Anaesthesiol Scand; 2016 May; 60(5):607-15. PubMed ID: 26763649
[TBL] [Abstract][Full Text] [Related]
10. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
[TBL] [Abstract][Full Text] [Related]
11. Effect of vasopressin and somatostatin on hemodynamics and blood gases in patients with liver cirrhosis.
Naeije R; Hallemans R; Mols P; Mélot C; Reding P
Crit Care Med; 1982 Sep; 10(9):578-82. PubMed ID: 6125342
[TBL] [Abstract][Full Text] [Related]
12. Treatment of portal hypertension with isosorbide dinitrate alone and in combination with vasopressin.
Hallemans R; Naeije R; Mols P; Mélot C; Reding P
Crit Care Med; 1983 Jul; 11(7):536-40. PubMed ID: 6861502
[TBL] [Abstract][Full Text] [Related]
13. Haemodynamic response to intravenous vasopressin and nitroglycerin in portal hypertension.
Westaby D; Gimson A; Hayes PC; Williams R
Gut; 1988 Mar; 29(3):372-7. PubMed ID: 3128465
[TBL] [Abstract][Full Text] [Related]
14. Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension.
Groszmann RJ; Kravetz D; Bosch J; Glickman M; Bruix J; Bredfeldt J; Conn HO; Rodes J; Storer EH
Hepatology; 1982; 2(6):757-62. PubMed ID: 6815044
[TBL] [Abstract][Full Text] [Related]
15. Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.
García-Pagán JC; Escorsell A; Feu F; Bandi JC; Moitinho E; Casado M; Bosch J; Rodés J
J Hepatol; 1996 Apr; 24(4):430-5. PubMed ID: 8738729
[TBL] [Abstract][Full Text] [Related]
16. Nitroglycerin for portal hypertension. A controlled comparison of the hemodynamic effects of graded doses.
Rector WG; Hossack KF; Ready JB
J Hepatol; 1990 May; 10(3):375-80. PubMed ID: 2114438
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of a combination of vasopressin and ketanserin in patients with hepatitis b-related cirrhosis.
Lee FY; Tsai YT; Lin HC; Lee SD; Hsia HC; Lin WJ; Wang SS; Lai KH; Lo KJ
J Hepatol; 1992 May; 15(1-2):54-8. PubMed ID: 1506656
[TBL] [Abstract][Full Text] [Related]
18. Effects of vasopressin on haemodynamics in portal hypertensive rats receiving clonidine.
Moreau R; Cailmail S; Lebrec D
Liver; 1994 Feb; 14(1):45-9. PubMed ID: 8177029
[TBL] [Abstract][Full Text] [Related]
19. The effect of vasopressin and triglycyl lysine vasopressin (glypressin) on the splanchnic circulation in cirrhotic patients with portal hypertension.
Rabol A; Juhl E; Schmidt A; Winkler K
Digestion; 1976; 14(3):285-9. PubMed ID: 955334
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
Lin HC; Yang YY; Hou MC; Huang YT; Lee WC; Lee FY; Chang FY; Lee SD
Scand J Gastroenterol; 2002 Apr; 37(4):482-7. PubMed ID: 11989841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
